Dutch gene therapy pioneer raises $82 mln in U.S. IPO-Reuters
A small Dutch company behind the Western world's first approved gene therapy priced its shares above the expected range in a U.S. stock offering on Wednesday, showing the current investor appetite for biotechnology.
6 February 2014•2 mins read
